Product Description: Taltobulin trifluoroacetate (HTI-286 trifluoroacetate), a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Taltobulin trifluoroacetate inhibits the polymerization of purified tubulin, disrupts microtubule organization in cells, and induces mitotic arrest, as well as apoptosis[1].
Applications: Cancer-programmed cell death
Formula: C29H44F3N3O6
References: [1]Loganzo F, et al. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Res. 2003 Apr 15;63(8):1838-45.
CAS Number: 228266-41-9
Molecular Weight: 587.67
Compound Purity: 99.08
Research Area: Cancer
Solubility: DMSO : ≥ 39 mg/mL
Target: ADC Cytotoxin;Apoptosis;Microtubule/Tubulin